GitLab
Forecast impact
Track in portfolio
Price chart
Description
Company and Business Model
GitLab is a technology company that provides a DevOps platform for software development, enabling teams to collaborate on code, manage projects, and automate workflows. Its core products include source code management, continuous integration and delivery, and security features. Major business segments encompass enterprise solutions and cloud services, with primary revenue sources derived from subscriptions and professional services.
Investment Profile
The investment profile of GitLab is more aligned with growth investors, given its focus on expanding its market presence and enhancing product offerings. The company shows potential for revenue growth, although it carries a higher risk profile. Investors seeking a balanced approach may find it suitable, but the absence of dividends limits its appeal for income-focused strategies.
Fundamental metrics (experimental) Updated: 2026-09-06
- EPS (TTM) — earnings per share for the last 12 months, $
- -0.32
- Revenue QoQ — quarter-over-quarter revenue growth
- 8.4%
- EPS surprise
- 33.5%
- 20d volatility
- 3.6%
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-09-10 | Buy | Hold | Mixed signals; monitor for improved fundamentals and momentum. |
| 2026-08-29 | Hold | Buy | Strong momentum and positive EPS surprise support growth outlook. |
| 2026-08-13 | Buy | Hold | Positive momentum, but fundamentals show weakness. |
| 2026-08-04 | Hold | Buy | Positive momentum, but fundamentals show weakness. |
| 2026-07-21 | Sell | Hold | Positive momentum, but fundamentals show weakness. |
| 2026-07-13 | Hold | Sell | Weak fundamentals and high risk limit upside potential. |
| 2026-06-27 | Sell | Hold | Mixed performance; high risk with uncertain fundamentals. |
| 2026-06-15 | Hold | Sell | Weak fundamentals and negative momentum raise concerns. |
| 2026-05-08 | — | Hold | Recent gains offset by high volatility and negative momentum. |
| 2026-05-04 | Sell | Hold | Компания показывает положительную динамику в краткосрочной перспективе, однако долгосрочные показатели остаются негативными, что указывает на высокие риски. |
| 2026-04-09 | Hold | Sell | Компания демонстрирует значительное снижение цены акций за последние месяцы, а отрицательный EPS указывает на финансовые проблемы. Растущий риск и низкий потенциал роста делают акцию менее привлекательной для инвестирова |
| 2026-04-01 | Sell | Hold | Компания демонстрирует рост выручки, но отрицательный EPS и значительное падение акций за последние месяцы указывают на высокие риски. Рекомендуется удерживать акции до более ясных сигналов о восстановлении. |
| 2026-03-17 | Hold | Sell | scenario_deterioration |
| 2026-03-11 | Sell | Hold | Компания демонстрирует значительное снижение цены акций за последние месяцы, а отрицательный EPS указывает на финансовые трудности. Растущий риск и низкий потенциал роста делают акцию менее привлекательной для инвестиций |
| 2026-01-30 | Hold | Sell | Акции GitLab демонстрируют значительное снижение на протяжении последних месяцев, что указывает на высокие риски. Отсутствие данных о прибыли и выручке также создает неопределенность в оценке компании. |
| 2026-01-23 | Sell | Hold | Компания показывает волатильность на рынке, с недавним ростом, но долгосрочные показатели остаются нестабильными. Рекомендуется удерживать акции до получения более ясных сигналов о стабильности. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-09-02 | D.A. Davidson | Target Raised | 45 → 55 | 51.38 |
| 2026-09-02 | UBS | Target Raised | 40 → 50 | 45.09 |
| 2026-09-02 | Needham | Target Raised | — → 65 | 45.09 |
| 2026-09-02 | Canaccord Genuity | Target Raised | 40 → 70 | 45.09 |
| 2026-09-02 | Morgan Stanley | Target Raised | 30 → 57 | 45.09 |
| 2026-09-02 | Piper Sandler | Target Raised | 28 → 52 | 45.09 |
| 2026-09-02 | Truist Financial | Target Raised | — → 48 | 45.09 |
| 2026-09-02 | BTIG | Target Raised | — → 60 | 45.09 |
| 2026-09-02 | Barclays | Target Raised | 25 → 47 | 45.09 |
| 2026-09-02 | Wells Fargo | Target Raised | — → 26 | 45.09 |
| 2026-08-31 | Cantor Fitzgerald | Target Raised | — → 50 | 44.87 |
| 2026-08-25 | Wells Fargo | Target Raised | 26 → 40 | 42.03 |
| 2026-08-21 | UBS | Update | — → 40 | 42.08 |
| 2026-08-20 | Truist Financial | Target Raised | 30 → 40 | 42.6 |
| 2026-08-19 | Mizuho Securities | Target Raised | 28 → 34 | 41.5 |
| 2026-08-14 | RBC Capital | Target Raised | 29 → 46 | 43.35 |
| 2026-07-10 | UBS | Target Raised | 32 → 35 | 34.16 |
| 2026-07-09 | Truist Financial | Target Raised | 25 → 30 | 31.74 |
| 2026-06-03 | D.A. Davidson | Target Raised | 24 → 35 | 30.38 |
| 2026-06-03 | UBS | Target Raised | 24 → 32 | 30.15 |
| 2026-06-03 | Wolfe Research | Target Raised | 32 → 36 | 31.82 |
| 2026-06-03 | BTIG | Target Raised | 30 → 36 | 31.82 |
| 2026-06-03 | Morgan Stanley | Target Raised | 29 → 30 | 31.82 |
| 2026-06-03 | Cantor Fitzgerald | Target Raised | — → 35 | 31.82 |
| 2026-06-03 | Mizuho Securities | Target Raised | — → 28 | 31.82 |
| 2026-06-03 | Needham | Target Raised | — → 38 | 31.82 |
| 2026-06-03 | RBC Capital | Target Raised | — → 29 | 31.82 |
| 2026-05-13 | Cantor Fitzgerald | Target Lowered | 30 → 27 | 22.3835 |
| 2026-05-12 | Mizuho Securities | Target Lowered | 30 → 26 | 25.64 |
| 2026-04-20 | RBC Capital | Rating Downgraded | — → 25 | 21.42 |
| 2026-04-16 | UBS | Rating Downgraded | — → 24 | 21.76 |
| 2026-03-09 | Morgan Stanley | Target Lowered | — → 29 | 24.58 |
| 2026-03-05 | Macquarie | Update | — → 26 | 25.765 |
| 2026-03-05 | D.A. Davidson | Target Lowered | — → 24 | 25.81 |
| 2026-03-04 | Bernstein | Target Lowered | — → 60 | 24.84 |
| 2026-03-04 | Canaccord Genuity | Target Lowered | — → 40 | 24.67 |
| 2026-03-04 | Piper Sandler | Update | — → 28 | 26.7 |